APC16 Inhibitors are a class of chemical compounds specifically designed to target and inhibit the APC16 protein, which is a subunit of the anaphase-promoting complex/cyclosome (APC/C). The APC/C is a crucial E3 ubiquitin ligase complex that plays a vital role in regulating the cell cycle, particularly during the transition from metaphase to anaphase. APC16, as one of the subunits of this complex, is involved in the proper assembly and function of the APC/C. It contributes to the recognition and ubiquitination of target proteins, marking them for degradation by the proteasome, which is essential for the orderly progression of the cell cycle. APC16 Inhibitors function by binding to specific sites on the APC16 protein, disrupting its interaction with other subunits of the APC/C or interfering with its role in substrate recognition and ubiquitination. This inhibition can impair the overall function of the APC/C complex, leading to a disruption in the regulated degradation of key cell cycle proteins.
The chemical structure and properties of APC16 Inhibitors are carefully designed to ensure high specificity and efficacy in targeting the APC16 protein. These inhibitors are often engineered to interact precisely with the regions of APC16 involved in protein-protein interactions or in the catalytic processes of the APC/C complex. For example, the inhibitors may include hydrophobic groups that fit into non-polar binding pockets or polar and charged groups that form hydrogen bonds or ionic interactions with critical amino acid residues within APC16. Additionally, the inhibitors are optimized for solubility, stability, and bioavailability to ensure that they can effectively reach and bind to APC16 in the cellular environment. The binding kinetics, such as the rates of association and dissociation between the inhibitor and APC16, are critical factors that influence the potency and duration of inhibition. By studying the interactions between APC16 Inhibitors and the APC/C complex, researchers can gain valuable insights into the mechanisms of cell cycle regulation and the broader implications of APC16's role in maintaining cellular homeostasis. Understanding these interactions is essential for elucidating the complex processes that govern cell division and the controlled degradation of cell cycle regulators.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Binds to DNA and inhibits RNA polymerase, thus blocking transcription and potentially reducing APC16 expression. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Inhibits eukaryotic protein synthesis by blocking ribosomal translocation, which could decrease APC16 protein levels. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits the mTOR pathway, which could lead to a broad reduction in protein synthesis, including APC16. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Interacts with DNA by intercalation and inhibits topoisomerase II, which can suppress transcription and protein synthesis. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Forms DNA crosslinks, hindering DNA replication and transcription, potentially decreasing APC16 expression. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
A nucleotide analog that disrupts RNA synthesis and function, which could indirectly inhibit APC16 expression. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Inhibits ribonucleotide reductase, decreasing the pool of dNTPs for DNA synthesis, affecting APC16 expression. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Specifically inhibits RNA polymerase II, blocking mRNA production for proteins including APC16. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A proteasome inhibitor that could lead to altered regulation of cell cycle proteins and affect APC16 levels indirectly. | ||||||
Mycophenolic acid | 24280-93-1 | sc-200110 sc-200110A | 100 mg 500 mg | $69.00 $266.00 | 8 | |
Inhibits inosine monophosphate dehydrogenase, potentially affecting nucleotide synthesis and APC16 expression. | ||||||